Cambridge Investment Research Advisors, Inc. Gossamer Bio, Inc. Transaction History
Cambridge Investment Research Advisors, Inc.
- $27.1 Billion
- Q2 2024
A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Gossamer Bio, Inc. stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 16,000 shares of GOSS stock, worth $17,120. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16,000
Previous 15,000
6.67%
Holding current value
$17,120
Previous $18,000
22.22%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding GOSS
# of Institutions
101Shares Held
175MCall Options Held
453KPut Options Held
543K-
Nea Management Company, LLC Timonium, MD18.1MShares$19.4 Million1.54% of portfolio
-
Artal Group S.A. Luxembourg, N413.3MShares$14.2 Million0.76% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$12.6 Million0.0% of portfolio
-
Octagon Capital Advisors LP New York, NY9.19MShares$9.83 Million1.91% of portfolio
-
Arch Venture Management, LLC Chicago, IL8.06MShares$8.62 Million4.25% of portfolio
About Gossamer Bio, Inc.
- Ticker GOSS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 93,954,000
- Market Cap $101M
- Description
- Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...